Federal Register #2026-22955

DEA Registration Revocation and Application to Import Schedule I Controlled Substances

This Department of Justice notice combines a DEA registration revocation with an application to import Schedule I controlled substances. - Government buyer: U.S. Department of Justice, Drug Enforcement Administration (DEA). - Regulatory actions: - The DEA revoked Troy R. Lehman, D.O.’s Oklahoma practitioner registration, No. BL7481649, and denied pending renewal, modification, and additional-registration applications. The agency cited lack of state authority and materially false answers on five renewal applications. - NSI Lab Solutions LLC applied to register as an importer of three Schedule I controlled substances. The notice allows comments, objections, or hearing requests. - Substances named in the import application: - Amineptine — drug code 1219; quantity not stated. - Mesocarb — drug code 1227; quantity not stated. - 3-Fluoro-N-methylcathinone (3-FMC) — drug code 1233; quantity not stated. - No products or services are being procured, and no contract award or performance period is specified.

Description

The Drug Enforcement Administration issued a decision and order revoking Troy R. Lehman, D.O.’s DEA registration, No. BL7481649. The order finds that he lacked state authority to handle controlled substances in Oklahoma and materially falsified his registration renewal applications. It also denies pending applications to renew or modify the registration and any other pending application for additional registration in Oklahoma. The order is effective December 14, 2026.

View original listing